If you haven’t had a chance to read this, check out this important information about Corwood that appeared in GCI…

CORWOOD’S ADVANCED SYMEX MANUFACTURING AND PROCESSS TECHNOLOGY UP AND RUNNING

Hauppauge, New York, September 8, 2006 – Corwood Laboratories, Inc. announces that their $19MM investment in manufacturing and processing technology, the latest advancement in the company’s robust commitment to expanding its manufacturing and technical capabilities to customers, is already providing advantages.

Vincent Penna, Corwood’s Vice President of Sales and Marketing said, “The addition of our new state-of-the-art facilities includes Symex processing equipment. Corwood’s investment in this expansion project is key to where we are headed. Symex is a leader in the development of processing equipment for the cosmetic and pharmaceutical industries. If fact, in the United States and Europe, Symex has been involved in the design and development for some of the world’s most prestigious pharmaceutical and biotech companies.”

Mr. Penna added, “Overall, our substantial investment is already resulting in increased formula integrity and process security. Our expansion also includes the addition of the very latest computerized analytical and testing equipment, featuring Gas Chromatograph, H.P.L.C., F.T.I.R. and Spectrophotometer.”

It was explained that these analytical tools are providing precise formula and raw material evaluations and complement additional testing equipment that can measure product characteristics. “In our 37-year history, Corwood has continually reinvested in its research and development capabilities and now moves to a new level of service for its customers”, he added.

“Our substantial industry experience combined with our new capabilities has stepped up our ability to work with our customers as a partner in their product development efforts – from the earliest product development phase until products are ready to reach the marketplace. Now, more than ever, we are aggressively telling our customers that when they bring their newest ideas to us, we are in the position to transform them into product realities”, stated Mr. Penna.

In keeping with supporting customers with new ideas, Mr. Penna added that Corwood has formed a highly experienced technical and marketing team from within its ranks who will be focused on anticipating and supporting the needs of its customers by advancing their product development concepts. Mr. Penna said an announcement about this latest Corwood capability would soon be released to the industry.

CORWOOD AND BIOZONE LAUNCH QUSOMES^® THROUGH STRATEGIC ALLIANCE

Hauppauge, New York, April 11, 2006 – Vincent Penna, Vice President, Sales and Marketing, Corwood Laboratories, announced that in conjunction with BioZone Laboratories, they are now offering QuSomes^®, a new, patented, state-of-the-art, next generation delivery system for cosmetic and personal care products that has been proven to outperform liposomes in the marketplace.

“QuSomes (INCI names PEG-12 Glyceryl Distearate and PEG-12 Glyceryl Dioleate) are the next generation of nanotechnology, and are destined to make their mark in our industry among cosmetic and personal care manufacturers. Clearly, our joint venture with BioZone Laboratories is not only a major step for our two companies, but signals an important industry event,” Mr. Penna stated.

Through extensive in vitro and clinical testing, QuSomes exceed liposomes when it comes to performance and efficacy in breakthrough skin care products. Mr. Penna said, “Up until now, liposomes have been the standard in the research and development of skin care and cosmetic products. In clinical testing, QuSomes consistently demonstrate that they enhance the skin permeation of ingredients, allowing the ingredient to stay in the skin longer and improve the product’s performance when compared to formulations that incorporate liposomes. Additionally, QuSomes have been featured in a number of consumer products, and are proven to overcome the limitations of traditional liposomes. They offer enormous advantages for the manufacturers of skin care products as well as noticeable benefits for consumers who are constantly seeking long lasting improvement in their appearance.”

The breakthrough is so significant that the latest edition of Handbook of Cosmetic Science and Technology has dedicated an entire chapter to QuSomes written by Brian Keller, Ph. D. and Co-Founder of BioZone Laboratories.

Dr. Keller commented, “QuSomes represent a technological advance that the industry is truly looking for. He added, “BioZone’s legacy of breakthrough innovations, chemical processes, research and development as well as overall technical and manufacturing ability perfectly complement Corwood’s substantial strengths in the personal care and cosmetics industries.”

Corwood and BioZone were enthusiastic in reporting the launch of this breakthrough technology and emphasized that their strategic alliance is a mutually beneficial venture. The two companies have established a “blue sky” research and development team, known as the Advanced Concepts and Products (ACAP) Team, whose goal is to discover and apply new technologies to the cosmetic, personal care and pharmaceutical industries. Because each side brings different capabilities, they jointly provide the technical and marketing expertise that is needed to dominate the highly competitive skin care and cosmetics market.

Mr. Penna pointed out Corwood’s long-standing dedication and reinvestment of its assets has been key to its substantial growth. “Corwood has invested more than $20 million in manufacturing capabilities. We’ve also built a reputation for personal service, flexibility, and attention to detail. The personal commitment and customer relationships forged by our President and CEO, Irwin Thaler, and cultivated by our staff are exemplary assets – virtually priceless in today’s competitive environment.”